SCHEMBL9852714

SCHEMBL9852714

O=C(CO)OCC1CCCCC1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.63
SLC1A3 P43003 3/20 0.41
SLC1A2 P43004 3/20 0.41
SLC1A1 P43005 3/20 0.41
MIF P14174 1/20 0.40
PARP15 Q460N3 2/20 0.39
PARP10 Q53GL7 2/20 0.39
EPHX1 P07099 3/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
ALOX5 P09917 1/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NAAA Q02083 1/20 0.35
MGLL Q99685 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12304458 0.98 LMNA (0.60) LMNASLC1A3SLC1A2SLC1A1MIF
SCHEMBL4004096 0.84 LMNA (0.66) LMNASLC1A3SLC1A2SLC1A1MIF
SCHEMBL9208258 0.84 LMNA (0.85) LMNASLC1A3SLC1A2SLC1A1MIF
SCHEMBL14620899 0.83 LMNA (0.44) LMNASLC1A3SLC1A2SLC1A1PARP15
SCHEMBL1734351 0.82 LMNA (0.62) LMNASLC1A3SLC1A2SLC1A1MIF
SCHEMBL27471005 0.82 LMNA (0.81) LMNASLC1A3SLC1A2SLC1A1MIF
SCHEMBL8393966 0.81 LMNA (0.61) LMNASLC1A3SLC1A2SLC1A1MIF
SCHEMBL202557 0.81 LMNA (0.61) LMNASLC1A3SLC1A2SLC1A1MIF
SCHEMBL8403203 0.81 LMNA (0.61) LMNASLC1A3SLC1A2SLC1A1MIF
SCHEMBL8392748 0.81 LMNA (0.61) LMNASLC1A3SLC1A2SLC1A1MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111234180-B Resin composition and hardened resin composition 财团法人工业技术研究院 2022-06-14 CN disclosed
CN-111234180-A Resin composition and hardened resin composition 财团法人工业技术研究院 2020-06-05 CN disclosed
EP-0437016-A2 Lipid A analogues having immunoactivating and anti-tumour activity Sankyo Company Limited (JP) 1991-07-17 EP disclosed
EP-0363223-A2 3-Aryloxymethyl-cephalosporin derivatives, their preparation and their medical use Sankyo Company Limited (JP) 1990-04-11 EP disclosed